1. Hospital CEOs are bullish
Martha says Medtronic didn’t take as hard a hit from the slowdown of elective procedures. He gives partial credit to the company’s rollout of new products, reporting that the company has been able to grab market share.
Medtronic is “selling at record numbers” of capital equipment, including energy-based therapies, imaging, surgical navigation equipment and robots.
“We believe this is leading to a bounce-back or snapback of procedures in the U.S.,” he said. “Europe will lag by a few months, but we’re experiencing something similar there.”